Fact CheckerSign in

NCT06336577Completed

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Source: ClinicalTrials.gov · Last updated 15 Aug 2024

Brief summary (registry, in English)

The purpose of this study is to describe infectious and non-infectious lower respiratory tract diseases in children with Down syndrome followed in pediatric pulmonology consultations in Ile de France.

Status (registry)
Completed
Study type
Observational
Enrollment
108 (actual)
First submitted
22 Mar 2024
Start date
28 Mar 2024
Primary completion date
26 Jun 2024
Lead sponsor
Centre Hospitalier Sud Francilien
Diseases
Asthma
NCT number
NCT06336577

What you commit to

  • Study type: Observational
  • Participants enrolled: 108
  • From 28 Mar 2024 to the primary completion date, 26 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient under guardianship or curators
  • Adult or holders of parental authority informed of the study and having objected to it

Who the study is looking for

  • Child from 0 to 17 years old
  • Carrier of Down syndrome confirmed by karyotype
  • Having had follow-up in a pediatric pulmonology consultation for an infectious or non-infectious lower respiratory tract
  • Not exclusively presenting upper respiratory otorhinolaryngological damage

Age in the registry: 1 day to 17 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Hospitalier Sud Francilien
Coordinator of this site? Confirm its status
Corbeil-EssonnesFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.